Clinical Trials Browser

rocakinogene sifuplasmid × Gastrointestinal × 1 year × Clear all

NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

Phase 1 Active not recruiting

Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular